The data on visceral mycoses reported in theAnnual of Pathological Autopsy Cases in Japanwere analyzed epidemiologically every four years from 1989 to 2005, and in 2007. The frequency rates of visceral mycoses dropped sharply between 1989（4.5%）and 1994（3.2%） , but by 2001 had risen again and have remained（4.4-4.6%）generally stable since then. The predominant causative agents were Candida and Aspergillus. Although the rate of candidosis showed a gradual decrease, the rate of aspergillosis showed an increase by degrees. Furthermore, the rate of aspergillosis exceeded that of candidosis in 1994, and the difference in the rates between the two conditions apparently further increased until 2001. After 2005, however no changes in this difference were observed. For complicated infections, the incidence of coinfection with Aspergillus and Candida showed a decreasing, and that with Aspergillus and Zygomycetes showed an increasing tendency. Severe infections with Zygomycetes showed a clear increase from 57.4% in 1989 to 88.9% in 2007. Comparing underlying diseases with mycoses in 1989 and 2007, leukemia（including myelodysplastic syndrome）decreased from 26.1% to 18.8% and bacterial infections（including interstitial pneumonia）increased from 11.1% to 22.1%. By age, the highest frequency rate of mycoses was observed in the range of 60-79 years, and the frequency rate of exogenous fungal infections such as aspergillosis, cryptococcosis, zygomycosis and trichosporonosis showed an increasing trend in the less than one-year old group.
INTRODUCTION
Many recent reports have described an increase in the incidence of invasive fungal infections, including aspergillosis , and candidosis caused by non-albicans Candida spp.
12−15）
in immunocompromised patients and/or in a nosocomial setting. Moreover, the risk of contracting infection is higher in these patients. Although the likelihood of this risk should be considered in the present clinical settings, there are no detailed reports on visceral mycoses in autopsy cases in the survey at the national level. data on mycoses from autopsy cases; however, few reports have focused on recent trends in infection rates. The study by Miyake and Okudaira covered trends spanning the 13 years between 1948 and 1961 16） , and that by Hotchi et al. and Kume 20−21） indicated that the frequency of visceral mycoses increased markedly from 1.60% in 1969 to 4.66% with a peak in 1990. Among the mycoses, the incidences of candidosis and aspergillosis were the highest. From 1990 to 1994, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent in the cases of monopathogen infection was Candida, followed by Aspergillus and Cryptococcus. Although the rate of candidosis has decreased considerably from 1990, that of aspergillosis has continued to increase and surpassed that of candidosis in 1991. The rate of aspergillosis increased conspicuously in 1997（Aspergillus, 40.9%; Candida, 34.8%） , and in 2001 the rate was even higher（Aspergillus, 46.0%; Candida, 27.4%）
21）
. From 2001 onward, the frequency of visceral mycosis showed a tendency to decrease slightly （Fig 1） . To clarify the recent trends concerning the frequency of these mycoses in autopsy cases, we epidemiologically analyzed the data reported in theAnnual of the Pathological Autopsy Cases in Japan 22−27） . Here, we describe in greater detail a recent trend in the frequency of infections, including the latest results retrieved. （This study was reported in part at the 17th Congress of the International Society for Human and Animal Mycology, Tokyo, Japan, 2009.） 
MATERIALS AND METHODS
Diagnostic criteria: The description of each case is the responsibility of a reporting pathologist and depends on his or her ability to make a diagnostic determination.
Mycoses are defined as infections caused by eumycotic organisms such as Candida, Aspergillus, Cryptococcus, Zygomycetes, Trichosporon, and other fungal species. Infections caused by filamentous bacteria such as Actinomycetes （Actinomyces, Nocardia, and Streptomyces spp.） , and pneumocystis pneumonia were excluded from the criteria of mycoses in accordance with the definition in our first series of epidemiological research. Superficial infections such as dermatophytoses were excluded from the category of visceral mycoses. The termcomplicated infectionrefers to a mixed infection caused by 2 or more kinds of fungi. Severe mycotic infections from autopsy records can be defined as follows: （1）direct cause of death,（2）severe pulmonary infection involving both lobes of the lung,（3） severe visceral infections of 2 or more organ systems, including those involving the central nervous system,（4）multiorgan systemic infection of 3 or more organ systems, or（5）a case described as fungemia. Table 4 .
The frequency of infected foci and/or ratio of causative agent by infected foci: The frequency of infected foci and the ratio of causative agents in the to 698 cases with monopathogen infections reported in 2007 are shown in Fig. 2 and Table 5 . The frequency rate of infection in the respiratory system was the highest（51.6%） , followed by systemic infection（10.3%） . In respiratory system （lungs and bronchia）infection, the frequency of aspergillosis was the highest（72.2%） , and in kidney and urinary system infection, the frequency of candidosis was the highest（46.7%） , according to the ratio of infected foci by causative agents. Moreover, cryptococcosis accounted for 58.3% of the infection of the central nervous system（brain and/or meninx） , and 72.7% of fungemia was caused by candidosis. Furthermore, digestive canal（intestine, esophagus, and stomach）infections caused by Candida also occurred with high frequency（data not shown） . On the other hand, according to the results for infected foci by causative agents in 2007, in the cases of aspergillosis, the respiratory system was found to be the most commonly infected organ （260/324, 76.0%） , followed by systemic organs （22/324, 6.8%） . In the cases of candidosis, digestive canal infections（included in the category of other organs in Table 5 .
Changes in underlying disease between 1989 and 2007: A comparison of the proportions of underlying diseases in 1989 and 2007 is shown in Fig. 3 . In 1989, among a total of 1,673 cases with visceral mycosis, leukemia including MDS was the major underlying disease（436/1,673, 26.1%） , followed including interstitial pneumonia and collagen diseases.
Frequency of cases with visceral mycosis by age and causative agent: In each annual retrieval evaluation, the highest frequency of mycoses was observed in the age range of 60-69 and/or 70-79 years（the average frequency was 27.8%） . On the other hand, candidosis showed a decreasing tendency in this age range, from 82.6% in 1989 to 37.5% in 2007; the frequency of exogenous fungal infections such as aspergillosis, cryptococcosis, zygomycosis and trichosporonosis by age showed an increasing tendency in those less than one year old; that is, the incidence of aspergillosis increased from 8.7% in 1989 to 37.5% in 2007, and that of cryptococcosis increased from 0% in 1989 and 2005 to 12.5% in 2007 as shown in Table 6 .
DISCUSSION
Epidemiological research on visceral mycosis in autopsy cases is scarce 28−31） , and none of the epidemiological studies performed in foreign countries has focused on autopsy cases reported in the entire country. In this epidemiological study, we retrospectively analyzed the autopsy data compiled by the Japanese Society of Pathology and those collected from university hospitals, public hospitals, and large-scale private hospitals in Japan. The frequency of visceral mycoses in the cases with leukemia and MDS was clearly 4-6 times higher than that of visceral mycoses in cases with all underlying diseases. According to previous reports, mycosis was more frequently noted in cases of leukemia, such as acute lymphatic leukemia, acute myeloid leukemia, and chronic myeloid leukemia, than in cases with other underlying diseases, including blood and hematopoietic system disease 17−20） . The frequency of mycoses was especially high in leukemia patients who had undergone bone marrow transplantation（BMT）
2）
. Leventakos et al.
32） showed that invasive fungal infections（IFIs）remain an important cause of morbidity and mortality in patients with acute or chronic leukemia. The frequency of fungal infection could be higher in patients with leukemia and MDS because advancements in chemotherapy and BMT have enabled their survival even in an immunocompromised state. The frequency of visceral mycosis in autopsy cases decreased temporarily, as well as there being an annual change in the common causative agent, from 1989 to about 1993（as shown in Fig. 1 A remarkable increase in the frequency of aspergillosis was noted between 1993 and 2001, as shown in Table 2 . We speculate that the reason for this increase might be the lack of effective antifungal agents against this agent before 2001 and an increase in the number of severely immunosuppressed patients and/or increase in the number of patients infected with exogenous fungi who had decreased lung function including elderly patients and/or those with respiratory illness. Lass- Flörl C 13） indicated that the frequency of invasive fungal diseases due to Candida species has been decreasing, and pointed out such diseases by Candida species are no longer the majority in many institutions. However, the incidence of non-Candida invasive fungal diseases such as aspergillosis, zygomycosis, and fusariosis has increased. Samarakoon and Soubani
35）
showed that there have been an increasing number of reports on invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease（COPD） ; however, these reports do not focus on the classic risk factors for this severe infection. Although there is a difference in the frequency of candidosis between autopsy and clinical cases, this infection is considered a clinical problem. In recent years, many reports have suggested an increase in the incidence of refractory candidosis caused by non-albicans Candida spp.
36−41）
. Concia et al.
42）
showed that Candida spp. are increasingly responsible for causing bloodstream infections and are associated with high morbidity and mortality in both neutropenic and non-neutropenic critically ill patients.
Since 2001, there has been a slight decrease in the frequency of aspergillosis. We speculate that the reasons for this decrease might be the introduction of new effective antifungal agents for aspergillosis and the advancement in diagnostics and clinical efforts toward the diagnosis and treatment of this infection. The frequency of Aspergillus exposure might aoso be an important factor responsible for the decrease in incidence of aspergillosis 43−44） . However, the frequency of zygomycosis has tended to increase, as shown in Table 2 , and the number of complicated infection cases having aspergillosis and zygomycosis rose remarkably in 2007（Table 3） . In addition, the frequency of severe zygomycosis increased after 1993, as shown in Table 4 . Many recent epidemiological studies indicated that the frequency of zygomycosis has been increasing 7,45−46）
. These findings suggest that zygomycosis will be one of the most important visceral mycoses in the future for the following reasons: its diagnosis is difficult, frequency of severe infection and mortality rate are high 47 8） showed that there has been an in-crease in the frequency of invasive Trichosporon infection in patients with hematological malignancies. However, the frequency of trichosporonosis was low in the autopsy cases retrieved over 4 years, as described in the footnote to Table  2 . This could be because trichosporonosis is possibly diagnosed on the basis of pathologic histology as candidosis or as an unidentified fungal infection. Comparison between the data retrieved in 1989 and those retrieved in 2007 showed that there was a decrease in the incidence of leukemia including MDS as an underlying disease in visceral mycosis, as shown in Fig. 3 . We speculate that the following reasons are responsible for such a finding:（1）clinical recognition of visceral mycosis has improved;（2）clinical effort has been focused on the diagnosis and treatment of visceral mycoses including prophylaxis and an empirical therapy for patients with diseases such as leukemia who are admitted to the internal medicine department, and（3）the efficacy of new antifungal drugs for severe infections has improved. Recent studies suggest that there has been an increase in the incidence of exogenous infectious diseases in pediatrics departments 52−55）
. Our study also suggests the same tendency of increasing exogenous infections. Therefore, diagnostic measures need to be taken to detect visceral mycosis due to exogenous pathogens in babies. In recent years, new antifungal agents have become available, and various guidelines for the diagnosis and treatment of infectious diseases have been established. Nevertheless, the mortality rate in cases with nosocomial fungal infections is still high. Therefore, new therapeutic and preventative strategies need to be developed.
The results of our study suggest that clinicians should increasingly focus on visceral mycoses.
